Swedish company Cuviva is part of a new cross-border research initiative in health innovations and person-centred care.
The project has been awarded almost 3 million EUR by the EU among others. The research focuses on increasing the use of home dialysis, which has been shown to provide significant benefits for patients’ quality of life and health compared to traditional hospital-based dialysis, states the company.
The project aims to increase the use of home dialysis as a separate treatment method through a cross-border collaboration and innovative care solutions. By implementing dialysis at home, health is expected to improve, participation in working life will increase, and healthcare costs and environmental impact will decrease. The project is also expected to promote the development of value-creating services and product innovations in home dialysis and other long-term disease processes.
“With the Home Dialysis project we continue to develop the most complete platform for RPM, Hospital at Home and Selfcare and we are so much looking forward following the research performed in the project,” says Henrik Cederqvist, CEO and Co-founder of Cuviva.
The EU programme Interreg Öresund-Kattegat-Skagerrak is the main financier
The project has participants in patient associations, corporations, academia and industry from Sweden, Denmark, and Norway. The EU programme Interreg Öresund-Kattegat-Skagerrak is the main financier, but project partners in different countries also contribute with their resources.
“A sign that they see great benefit and feasibility in the 3-year project,” says Håkan Billig, principal investigator.
Photo of Håkan Billing: Cuviva